Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H17N3.ClH |
| Molecular Weight | 251.755 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C1CN=C(NC2=CC=CC3=C2CCCC3)N1
InChI
InChIKey=RZOXEODOFNEZRS-UHFFFAOYSA-N
InChI=1S/C13H17N3.ClH/c1-2-6-11-10(4-1)5-3-7-12(11)16-13-14-8-9-15-13;/h3,5,7H,1-2,4,6,8-9H2,(H2,14,15,16);1H
| Molecular Formula | C13H17N3 |
| Molecular Weight | 215.2942 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2093864 |
16.0 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Spray-Tish Approved UseSpray-Tish is a nasal decongestant. It works by clearing a stuffy or blocked nose by shrinking the inflamed and swollen blood vessels in the lining of the nose.
Spray-Tish relieves a stuffy or blocked nose (nasal congestion) associated with the common cold, hayfever and rhinitis. A runny nose, nasal congestion, itching and sneezing, are typical symptoms of a condition known as rhinitis. |
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.09 mg 4 times / day multiple, intranasal Recommended Dose: 0.09 mg, 4 times / day Route: intranasal Route: multiple Dose: 0.09 mg, 4 times / day Sources: |
unhealthy, CHILD|ADOLESCENT|ADULT Health Status: unhealthy Age Group: CHILD|ADOLESCENT|ADULT Sex: M+F Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effect of nasal steroid administration on intraocular pressure. | 2007-07 |
|
| Tramazoline turns asymptomatic into symptomatic hyper-CK-emia. | 2007-03 |
|
| The prevalence of allergic asthma and rhinitis in children of Polichni, Thessaloniki. | 2004-04-17 |
|
| [The tolerability of nasal drugs with special regard to preservatives and physico-chemical parameters]. | 2003-11 |
|
| Effects of topical mydriatics and vasoconstrictors on prostaglandin-E2-induced aqueous flare elevation in pigmented rabbits. | 2002-12-24 |
Patents
Sample Use Guides
The recommended dose for adults and children six years of age and over is 1 to 2 sprays into each nostril up to four times daily as required.
Route of Administration:
Nasal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6142954
Binding affinity of Tramazoline against Alpha-2 adrenergic receptor measured as the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was 16 nM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:53:25 GMT 2025
by
admin
on
Mon Mar 31 17:53:25 GMT 2025
|
| Record UNII |
4DG710Q678
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29709
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
14008-86-7
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
NON-SPECIFIC STOICHIOMETRY | |||
|
DTXSID00958350
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
SUB04928MIG
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
C005370
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
4DG710Q678
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
3715-90-0
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
223-064-3
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
m10997
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | Merck Index | ||
|
C87748
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
100000084659
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
19472
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL32573
Created by
admin on Mon Mar 31 17:53:25 GMT 2025 , Edited by admin on Mon Mar 31 17:53:25 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |